Soligenix, Inc. announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has exercised an option for the evaluation of RiVax®...

A biopharmaceutical company collaborating with Hawai’i scientists on an Ebola vaccine has announced encouraging news about its vaccine. Tests on the vaccine, still in development, have shown it is able...

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several...